Baird Medical Investment Holdings Limited (BDMD)

Market Cap	65.47M
Revenue (ttm)	33.05M
Net Income (ttm)	12.55M
Shares Out	35.78M
EPS (ttm)	0.43
PE Ratio	4.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	196,363
Open	2.140
Previous Close	2.330
Day's Range	1.680 - 2.190
52-Week Range	1.420 - 13.520
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BDMD

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company’s medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 148
• Stock Exchange: NASDAQ
• Ticker Symbol: BDMD
• Website: https://www.bairdmed.com

Financial Performance

In 2023, BDMD's revenue was $31.46 million, a decrease of -10.35% compared to the previous year's $35.09 million. Earnings were $10.55 million, a decrease of -16.09%.

Financial numbers in USD